HK1111356A1 - Method for reduction, stabilization and prevention of rupture of lipid rich plaque - Google Patents

Method for reduction, stabilization and prevention of rupture of lipid rich plaque

Info

Publication number
HK1111356A1
HK1111356A1 HK08102064.9A HK08102064A HK1111356A1 HK 1111356 A1 HK1111356 A1 HK 1111356A1 HK 08102064 A HK08102064 A HK 08102064A HK 1111356 A1 HK1111356 A1 HK 1111356A1
Authority
HK
Hong Kong
Prior art keywords
rupture
stabilization
prevention
reduction
lipid rich
Prior art date
Application number
HK08102064.9A
Other languages
English (en)
Inventor
Hideyuki Kobayashi
Yasunobu Yoshinaka
Kimiyuki Shibuya
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of HK1111356A1 publication Critical patent/HK1111356A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK08102064.9A 2004-12-10 2008-02-25 Method for reduction, stabilization and prevention of rupture of lipid rich plaque HK1111356A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63453204P 2004-12-10 2004-12-10
PCT/JP2005/023088 WO2006064889A1 (en) 2004-12-10 2005-12-09 Method for reduction, stabilization and prevention of rupture of lipid rich plaque

Publications (1)

Publication Number Publication Date
HK1111356A1 true HK1111356A1 (en) 2008-08-08

Family

ID=36587943

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08102064.9A HK1111356A1 (en) 2004-12-10 2008-02-25 Method for reduction, stabilization and prevention of rupture of lipid rich plaque

Country Status (12)

Country Link
US (2) US20090275595A1 (xx)
EP (1) EP1827440A4 (xx)
JP (1) JP2008522955A (xx)
KR (1) KR100895031B1 (xx)
CN (1) CN101068548B (xx)
AU (1) AU2005314810B2 (xx)
CA (1) CA2590224C (xx)
HK (1) HK1111356A1 (xx)
NZ (1) NZ554924A (xx)
RU (1) RU2351337C1 (xx)
TW (1) TW200619204A (xx)
WO (1) WO2006064889A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ544803A (en) * 2003-08-29 2009-11-27 Kowa Co Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
US8048083B2 (en) * 2004-11-05 2011-11-01 Dfine, Inc. Bone treatment systems and methods
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
CN102711763A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用医药组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
CA1336714C (en) * 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
JP2569746B2 (ja) * 1987-08-20 1997-01-08 日産化学工業株式会社 キノリン系メバロノラクトン類
US5177080A (en) * 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
ATE348607T1 (de) * 1995-11-02 2007-01-15 Warner Lambert Co Verfahren und pharmazeutische zusammensetzung zur regelung der lipidkonzentration
EP0987254B1 (en) * 1997-05-26 2004-12-22 Kowa Co., Ltd. Novel cyclic diamine compounds and medicine containing the same
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
AU7717500A (en) * 1999-09-30 2001-04-30 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
PL360398A1 (en) * 2000-07-13 2004-09-06 Takeda Chemical Industries, Ltd. Lipid-rich plaque inhibitors
PL362244A1 (en) * 2000-09-01 2004-10-18 Sankyo Company, Limited Medicinal compositions
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
MY140618A (en) * 2003-02-28 2009-12-31 Kowa Co Method for preparing acid addition salts of polyacidic basic compounds
US20060046996A1 (en) * 2004-08-31 2006-03-02 Kowa Co., Ltd. Method for treating hyperlipidemia

Also Published As

Publication number Publication date
NZ554924A (en) 2010-09-30
AU2005314810B2 (en) 2010-08-26
RU2351337C1 (ru) 2009-04-10
TW200619204A (en) 2006-06-16
KR100895031B1 (ko) 2009-04-24
CA2590224C (en) 2011-12-20
JP2008522955A (ja) 2008-07-03
EP1827440A4 (en) 2010-12-08
US20090275595A1 (en) 2009-11-05
WO2006064889A1 (en) 2006-06-22
RU2007125976A (ru) 2009-01-20
CN101068548B (zh) 2010-12-08
CA2590224A1 (en) 2006-06-22
KR20070085508A (ko) 2007-08-27
CN101068548A (zh) 2007-11-07
AU2005314810A1 (en) 2006-06-22
EP1827440A1 (en) 2007-09-05
US20110207742A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
EP1817857A4 (en) METHOD AND / OR SYSTEM FOR REDUCING PAPR
TWI369203B (en) Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
EP1733473A4 (en) PROC D AND SYSTEM ENSURING THE INNOCUIT OF THE SOUND LEVEL
EP1726567A4 (en) NANOROUS TITANIUM OXIDE AND MANUFACTURING METHOD THEREFOR
EP1869629A4 (en) SYSTEM AND METHOD FOR OFFERING TRAVEL SERVICES
HK1101347A1 (en) Fasudil-containing preparation and method of improving stability thereof
ZA200608195B (en) Improved configurations and methods for effluent gas treatment
ZA200700122B (en) Safety system and method
EP1863769A4 (en) HSP90 INHIBITORS, METHOD FOR THE PRODUCTION THEREOF AND THEIR APPLICATIONS
EP1805998A4 (en) SYSTEM AND METHOD FOR IMPROVED KNOWLEDGE OF SITUATIONS
MY144988A (en) Cigarette package and method of producing same
EP1736148A4 (de) Medizinische emulsion von perfluororganischen verbindungen und herstellungsverfahren dafür
EP1889853A4 (en) METHOD FOR MODIFYING PECTIN AND APPLYING THEREOF
EP1942225A4 (en) PAPER PROCESSING AND PAPER PROCESSING METHOD
EP1784164A4 (en) PROCESS FOR TRANSMEMBRANE TREATMENT AND PREVENTION OF OTITIS MEDIA
EP1893039B8 (en) Method for treatment and prevention of respiratory insufficiency
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
EP1765373A4 (en) OZONIZED PHARMACEUTICAL COMPOSITION AND METHOD THEREOF
EP1808222A4 (en) METHOD FOR SEPARATING COMPONENTS AND TRENCH UNIT
EP1603800A4 (en) MULTILAYER STRUCTURES, PACKAGING AND METHODS OF MANUFACTURING MULTILAYER STRUCTURES
HK1111356A1 (en) Method for reduction, stabilization and prevention of rupture of lipid rich plaque
EP1782821A4 (en) MEDICAMENT AND METHOD FOR IMPROVING BRAIN FUNCTION
EP1762610A4 (en) REDUCED DANCE, DANCE COMPLEX AND METHOD FOR USE THEREOF
HK1121098A1 (en) Method and structure for i-beam end geometry stabilization
EP1718631A4 (en) CYTOTOXIN COMPOUND AND METHOD OF ISOLATION

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141209